Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alcresta Infused With $10M Series B To Get First Product To Market

Jul 22 2013

• By Lisa LaMotta

Related Content

Alcresta Launches With Dynamic Business Model; Raises $10M Series A

Apr 17 2012

Alnara Execs Start Anew With Allena; $15 M Series A

Nov 16 2011

Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy

Jul 02 2010

Related Companies

Alcresta Therapeutics, Inc.

Eli Lilly and Company

Additional Topics

United States Strategy Business Strategies OTC Drugs Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window